Methylmalonic acidemia: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}}; {{AE}} | |||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = {{PAGENAME}} | | Name = {{PAGENAME}} | | ||
| Line 14: | Line 18: | ||
MeshID = | | MeshID = | | ||
}} | }} | ||
==Overview== | |||
'''Methylmalonic acidemia''' (MMA, also known as "methylmalonic aciduria") is an inborn error of intermediary [[metabolism]] that may present in the early [[neonatal]] period with progressive [[encephalopathy]] and death due to a secondary [[hyperammonemia]]. | '''Methylmalonic acidemia''' (MMA, also known as "methylmalonic aciduria") is an inborn error of intermediary [[metabolism]] that may present in the early [[neonatal]] period with progressive [[encephalopathy]] and death due to a secondary [[hyperammonemia]]. | ||
Methylmalonic acidemia does not always result in death, if it is diagnosed at an early age. | Methylmalonic acidemia does not always result in death, if it is diagnosed at an early age. | ||
== | ==Historical Perspective== | ||
==Types== | ==Classification== | ||
===Types=== | |||
* {{OMIM|251100}} - cblA type | * {{OMIM|251100}} - cblA type | ||
* {{OMIM|251110}} - cblB type | * {{OMIM|251110}} - cblB type | ||
| Line 36: | Line 37: | ||
Cobalmin (vitamin B12) is also needed for the conversion of methylmalonyl-CoA to Succinyl-CoA. Mutations leading to defects in cobalmin or in its transport frequently result in the development of acidemia. The numerous pat | Cobalmin (vitamin B12) is also needed for the conversion of methylmalonyl-CoA to Succinyl-CoA. Mutations leading to defects in cobalmin or in its transport frequently result in the development of acidemia. The numerous pat | ||
==Pathophysiology== | |||
==Causes== | |||
Methylmalonic acidemia is an inherited disorder in which the body is unable to process certain proteins and fats (lipids) properly. Methylmalonic acidemia is a disorder of [[amino acid metabolism]], involving a defect in the conversion of [[methylmalonyl-coenzyme A]] (CoA) to [[succinyl-CoA]] by [[methylmalonyl-CoA mutase]]. | |||
==Differentiating {{PAGENAME}} from Other Diseases== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural History, Complications, and Prognosis== | |||
==Diagnosis== | |||
===Diagnostic Criteria=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | |||
===Medical Therapy=== | |||
===Surgery=== | |||
===Prevention=== | |||
==See also== | ==See also== | ||
| Line 42: | Line 78: | ||
* [[Methylmalonic acid]] | * [[Methylmalonic acid]] | ||
== References == | ==References== | ||
* [http://www.oaanews.org Organic Acidemia Association] | * [http://www.oaanews.org Organic Acidemia Association] | ||
* {{NLM|methylmalonicacidemia}} | * {{NLM|methylmalonicacidemia}} | ||
* [http://www.whcenter.org/15171.cfm Washington Health Center] | * [http://www.whcenter.org/15171.cfm Washington Health Center] | ||
==References== | |||
{{reflist|2}} | |||
[[fr:Acidémie méthylmalonique]] | [[fr:Acidémie méthylmalonique]] | ||
{{Endocrine, nutritional and metabolic pathology}} | {{Endocrine, nutritional and metabolic pathology}} | ||
[[Category:Endocrinology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 16:53, 21 July 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
| Methylmalonic acidemia | |
 | |
|---|---|
| Methylmalonic acid | |
| ICD-10 | E71.1 |
| ICD-9 | 270.3 |
| DiseasesDB | 29509 Template:DiseasesDB2 |
| MedlinePlus | 001162 |
| eMedicine | neuro/576 |
Overview
Methylmalonic acidemia (MMA, also known as "methylmalonic aciduria") is an inborn error of intermediary metabolism that may present in the early neonatal period with progressive encephalopathy and death due to a secondary hyperammonemia.
Methylmalonic acidemia does not always result in death, if it is diagnosed at an early age.
Historical Perspective
Classification
Types
- Online Mendelian Inheritance in Man (OMIM) 251100 - cblA type
- Online Mendelian Inheritance in Man (OMIM) 251110 - cblB type
- Online Mendelian Inheritance in Man (OMIM) 277400 - cblC type
- Online Mendelian Inheritance in Man (OMIM) 277410 - cblD type
- Online Mendelian Inheritance in Man (OMIM) 277380 - cblF type
- Online Mendelian Inheritance in Man (OMIM) 606169 - cblH type
- Online Mendelian Inheritance in Man (OMIM) 251000 - mut type
Cobalmin (vitamin B12) is also needed for the conversion of methylmalonyl-CoA to Succinyl-CoA. Mutations leading to defects in cobalmin or in its transport frequently result in the development of acidemia. The numerous pat
Pathophysiology
Causes
Methylmalonic acidemia is an inherited disorder in which the body is unable to process certain proteins and fats (lipids) properly. Methylmalonic acidemia is a disorder of amino acid metabolism, involving a defect in the conversion of methylmalonyl-coenzyme A (CoA) to succinyl-CoA by methylmalonyl-CoA mutase.
Differentiating Methylmalonic acidemia from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
See also
References
- Organic Acidemia Association
- Methylmalonic acidemia at NLM Genetics Home Reference
- Washington Health Center